• Featured Product
  • KD/KO Validated

MAP2K3 Rekombinanter Antikörper

MAP2K3 Rekombinant Antikörper für WB, IF/ICC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte, Zebrafisch

Anwendung

WB, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

3O10

Kat-Nr. : 80137-1-PBS

Synonyme

MEK3, MAPKK 3, MAPK/ERK kinase 3, MAP kinase kinase 3, EC:2.7.12.2



Geprüfte Anwendungen

Produktinformation

80137-1-PBS bindet in WB, IF/ICC, Indirect ELISA MAP2K3 und zeigt Reaktivität mit human, Maus, Ratten, Zebrafisch

Getestete Reaktivität human, Maus, Ratte, Zebrafisch
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen Peptid
Vollständiger Name mitogen-activated protein kinase kinase 3
Berechnetes Molekulargewicht 347 aa, 39 kDa
Beobachtetes Molekulargewicht39 kDa
GenBank-ZugangsnummerBC032478
Gene symbol MAP2K3
Gene ID (NCBI) 5606
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

MAP2K3, also named MKK3, is a member of dual specificity kinase group and serves as a specific activator of p38 MAPK with MKK6. MKK3 can be phosphorylated by cytokines and environmental stress at sites Ser189 and Thr193 by MKKK proteins (MEKK 1-4). MKK3 plays a key role in cell differentiation, motility, division and death. It has been reported that MKK3 targeting may represent an effective and potentially safe therapeutic strategy to selectively kill cancer cells in colorectal cancer patients. (PMID: 31695024, 30770795, 26805700, 8622669)